Background
Method
Procedure
Participants
Assessments
Patient rated assessments
Quality of life
Symptom severity
Benefit from treatment
Sleep disturbance
Clinician rated assessments
Disturbance severity
Mean | (SD) |
n
|
Response
+
(%)
| |
---|---|---|---|---|
Patient rated variables
| ||||
Manchester Short Assessment of Quality of Life | 4.2 | (0.9) | 1902 | 84.7 |
Symptom Checklist – 10 | 2.4 | (0.7) | 2124 | 94.6 |
Benefit from Treatment | 2.9 | (1.1) | 1657 | 91.5 |
Clinician rated variables
| ||||
Health of Nations Outcome Scales sum++
| 7.8 | (4.5) | 1804 | 80.3 |
Global Assessment of Functioning - Function | 55.0 | (10.6) | 1945 | 86.6 |
Global Assessment of Functioning - Symptoms | 54.6 | (12.3) | 1945 | 86.6 |
Benefit from Treatment | 4.1 | (1.0) | 1721 | 95.0 |
Global assessment of functioning
Functioning
Symptom severity
Improvement from treatment
Primary diagnoses
Treatment duration
Types of care
Statistical analyses
Ethics
Results
Descriptive and preliminary analyses
n | (%) | Mean Level of Sleep Disturbance | (sd) | |
---|---|---|---|---|
Primary diagnoses
| ||||
Schizophrenia | 218 | (9.7) | 1.89 | (0.98) |
Mood disorders | 799 | (35.6) | 2.39 | (1.02) |
Anxiety disorders | 538 | (24.0) | 2.39 | (1.02) |
Personality disorders | 225 | (10.0) | 2.39 | (1.06) |
Other disorders | 175 | (7.8) | 2.39 | (1.06) |
No diagnosis | 291 | (13.0) | 2.32 | (1.06) |
Type of care
| ||||
Out-patients | 1754 | (78.1) | 2.34 | (1.04) |
In-patients | 492 | (21.9) | 2.31 | (1.01) |
Gender
| ||||
Female | 1127 | (51.0) | 2.36 | (1.04) |
Male | 1081 | (49.0) | 2.29 | (1.03) |
Results from steps 1 – 4 of the regression analyses
Hypothesis testing
Dependent variables | Adj. R2
| ΔR2
| B | S.E. B | β | t |
---|---|---|---|---|---|---|
Patient rated variables | ||||||
Quality of Life | 0.12 | 0.08 | −0.26 | 0.02 | −0.29** | 12.0 |
Symptom severity | 0.20 | 0.17 | 0.29 | 0.02 | 0.42** | 19.2 |
Benefit from treatment | 0.02 | 0.01 | −0.08 | 0.03 | −0.08* | 3.3 |
Clinician rated variables | ||||||
Disorder severity | 0.11 | 0.05 | 0.97 | 0.10 | 0.22** | 9.3 |
Level of functioning | 0.13 | 0.02 | −1.82 | 0.27 | −0.15** | 6.7 |
Symptom severity | 0.17 | 0.02 | −1.59 | 0.23 | −0.16** | 6.9 |
B | S.E. B | Wald | OR | |||
Benefit from treatment+
| 0.33 | 0.05 | 40.7** | 1.39 |